Search
Now showing items 1-1 of 1
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
Herrlinger, Ulrich et al. (2019)
Wissenschaftlicher Artikel